Kaleigh Stephenson
Family · Minden, LANPI 1336764604
Payments from drug & device makers
Across 74 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$219
- Merck$104
- Harmony Biosciences LLC$102
- AstraZeneca$86
- Otsuka America Pharmaceutical, Inc.$76
- Boehringer Ingelheim$64
- plus $709 from 24 others
What the payments were for
- Food & beverage$1,360100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 12 | $219 |
| Merck | 7 | $104 |
| Harmony Biosciences LLC | 4 | $102 |
| AstraZeneca | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Boehringer Ingelheim | 4 | $64 |
| Novartis | 4 | $59 |
| Biohaven Pharmaceuticals, Inc. | 1 | $59 |
| Vifor Pharma, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $45 |
| Johnson & Johnson | 3 | $44 |
| Mylan Specialty L.p. | 2 | $43 |
| Paratek Pharmaceuticals, Inc. | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Astellas Pharma US Inc | 2 | $30 |
| GSK | 1 | $29 |
| Indivior Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Biogen | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
| Fresenius USA Marketing, Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Athena Bioscience, LLC | 1 | $11 |
How this compares
$1,360 in reported general payments places this provider in the 65th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 34 | $38,043 |
| OzempicSemaglutide | 12 | $20,486 |
| JanuviaSitagliptin Phosphate | 15 | $17,908 |
| MounjaroTirzepatide | 13 | $13,545 |
| Tiotropium Bromide | 11 | $5,034 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $1,619 |
| LantusInsulin Glargine,hum.Rec.Anlog | 13 | $1,136 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $872 |
| Bupropion XlBupropion Hcl | 35 | $760 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $657 |
| Buspirone Hcl | 54 | $643 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $487 |
| Atorvastatin Calcium | 79 | $464 |
| Doxycycline Hyclate | 70 | $449 |
| Levocetirizine Dihydrochloride | 65 | $357 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $64 | $38,04334 claims |
| Novo NordiskOzempic | $18 | $20,48612 claims |
| MerckJanuvia | $104 | $17,90815 claims |
| Lilly USA, LLCMounjaro | $45 | $13,54513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,610 family providers in Louisiana.
Other family in Minden
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.